SCHEMBL8308362

SCHEMBL8308362

CC(=NO)c1ccc(-c2ccccc2)nc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 2/20 0.59
BAZ2B Q9UIF8 1/20 0.55
HPGDS O60760 2/20 0.47
PPARG P37231 1/20 0.41
KDM4E B2RXH2 1/20 0.41
P4HA1 P13674 1/20 0.40
P4HTM Q9NXG6 1/20 0.40
CASP3 P42574 1/20 0.40
GFER P55789 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
RXFP1 Q9HBX9 2/20 0.40
CYP3A4 P08684 1/20 0.39
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39
TRPV1 Q8NER1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14054202 0.79 LDHA (0.62) LDHABAZ2BHPGDSP4HA1P4HTM
SCHEMBL13100100 0.79 LDHA (0.73) LDHABAZ2BHPGDSP4HA1P4HTM
SCHEMBL8686143 0.77 LDHA (0.49) LDHABAZ2BHPGDSPPARGNPC1
SCHEMBL8304542 0.76 PPARG (0.54) LDHABAZ2BHPGDSPPARGNPC1
SCHEMBL8304541 0.76 PPARG (0.54) LDHABAZ2BHPGDSPPARGNPC1
SCHEMBL6935958 0.76 KDM4E (0.53) KDM4EP4HTMNPC1RAB9ATRPV1
SCHEMBL3368876 0.75 SMN1; SMN2 (0.56) PPARGKDM4ECASP3GFERSENP8
SCHEMBL4316450 0.75 SMN1; SMN2 (0.56) PPARGKDM4ECASP3GFERSENP8
SCHEMBL4888457 0.75 LDHA (0.62) LDHABAZ2BHPGDSP4HA1P4HTM
SCHEMBL505455 0.74 LDHA (1.00) LDHABAZ2BHPGDSP4HA1P4HTM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1056840-C Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2000-09-27 CN disclosed
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
CN-1143639-A Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-02-26 CN disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed